Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connie Hess

Concepts (264)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
50
2026
507
11.460
Why?
Lower Extremity
26
2026
453
4.240
Why?
Coronary Artery Disease
17
2024
751
4.120
Why?
Percutaneous Coronary Intervention
22
2021
550
4.110
Why?
Myocardial Infarction
19
2026
1215
3.560
Why?
Platelet Aggregation Inhibitors
30
2026
499
3.560
Why?
Fibrinolytic Agents
13
2025
303
3.210
Why?
Endovascular Procedures
9
2026
390
2.700
Why?
Radial Artery
9
2019
74
2.450
Why?
Purinergic P2Y Receptor Antagonists
8
2018
71
2.210
Why?
Rivaroxaban
16
2026
270
2.170
Why?
Vascular Surgical Procedures
8
2026
352
2.090
Why?
Aspirin
16
2026
405
2.090
Why?
Acute Coronary Syndrome
7
2023
299
2.070
Why?
Ischemia
9
2023
421
1.610
Why?
Femoral Artery
9
2024
183
1.600
Why?
Stroke
11
2026
1287
1.410
Why?
Hemorrhage
18
2026
825
1.310
Why?
Anticoagulants
11
2026
746
1.310
Why?
Treatment Outcome
43
2026
11821
1.300
Why?
Drug-Eluting Stents
4
2021
88
1.270
Why?
Anticholesteremic Agents
3
2023
156
1.220
Why?
Atherosclerosis
6
2024
410
1.180
Why?
Hypercholesterolemia
2
2022
95
1.180
Why?
Cholesterol, LDL
5
2024
363
1.160
Why?
Factor Xa Inhibitors
8
2026
195
1.150
Why?
Postoperative Complications
6
2021
3034
1.110
Why?
Coronary Vessel Anomalies
5
2026
38
1.100
Why?
Venous Thromboembolism
2
2023
332
1.090
Why?
Patient Readmission
4
2021
778
1.080
Why?
Cardiovascular Diseases
7
2024
2219
0.960
Why?
Aged
46
2026
26432
0.940
Why?
Disease Management
4
2021
651
0.930
Why?
Humans
105
2026
146342
0.930
Why?
Ticlopidine
3
2016
52
0.920
Why?
Vascular Diseases
5
2026
252
0.910
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2024
449
0.890
Why?
Saphenous Vein
2
2015
36
0.860
Why?
Atrial Fibrillation
4
2017
560
0.860
Why?
Risk Factors
31
2026
10921
0.860
Why?
Graft Occlusion, Vascular
2
2015
39
0.850
Why?
Learning Curve
2
2015
71
0.810
Why?
Cardiac Catheterization
3
2018
571
0.790
Why?
Middle Aged
44
2026
36619
0.780
Why?
Thrombosis
4
2024
398
0.780
Why?
Female
60
2026
79499
0.770
Why?
Fibrin Fibrinogen Degradation Products
1
2023
92
0.750
Why?
Male
53
2026
73396
0.740
Why?
Coronary Artery Bypass
2
2015
269
0.740
Why?
Warfarin
2
2015
179
0.740
Why?
Pyridones
2
2015
210
0.730
Why?
Coronary Vessels
4
2024
245
0.730
Why?
Antifibrinolytic Agents
1
2023
68
0.720
Why?
Postoperative Hemorrhage
2
2013
106
0.700
Why?
Sex Characteristics
3
2023
801
0.700
Why?
Brain Ischemia
2
2022
362
0.690
Why?
Diabetes Complications
2
2021
219
0.670
Why?
Registries
15
2026
2400
0.670
Why?
Paclitaxel
2
2021
260
0.670
Why?
Gout
2
2018
34
0.660
Why?
Blood Coagulation Disorders
1
2023
190
0.660
Why?
Heparin
3
2023
247
0.660
Why?
Hypolipidemic Agents
1
2021
89
0.640
Why?
Pyrazoles
2
2015
517
0.630
Why?
Angina Pectoris
2
2017
76
0.610
Why?
Drug Therapy, Combination
12
2026
1036
0.610
Why?
Dyslipidemias
1
2021
184
0.590
Why?
Leg
1
2021
246
0.580
Why?
Risk Assessment
12
2026
3712
0.560
Why?
Myocardial Revascularization
2
2016
85
0.550
Why?
Coronary Angiography
4
2024
325
0.550
Why?
Reperfusion
1
2018
53
0.550
Why?
Patient Care Team
1
2024
701
0.540
Why?
Time Factors
15
2026
7109
0.540
Why?
Upper Extremity
1
2018
114
0.500
Why?
American Heart Association
5
2024
364
0.480
Why?
Databases, Factual
2
2021
1493
0.470
Why?
Recurrence
6
2026
1133
0.440
Why?
Societies, Medical
3
2024
907
0.440
Why?
Quality Indicators, Health Care
3
2023
343
0.430
Why?
Acute Disease
4
2021
1038
0.430
Why?
Medicare
4
2021
920
0.420
Why?
Popliteal Artery
4
2024
60
0.420
Why?
Coronary Disease
1
2017
380
0.410
Why?
United States
24
2026
16136
0.410
Why?
Intermittent Claudication
3
2024
121
0.410
Why?
Secondary Prevention
3
2026
248
0.400
Why?
Randomized Controlled Trials as Topic
3
2024
1763
0.400
Why?
Hospitals
3
2017
738
0.390
Why?
Sex Factors
8
2026
2107
0.390
Why?
Cardiology
4
2024
363
0.390
Why?
Office Visits
1
2013
93
0.380
Why?
Follow-Up Studies
6
2021
5439
0.380
Why?
Hematoma
2
2022
62
0.350
Why?
Aftercare
1
2013
225
0.340
Why?
Subclavian Vein
1
2011
15
0.330
Why?
Subclavian Artery
1
2011
28
0.330
Why?
Arteriovenous Fistula
1
2011
36
0.320
Why?
Thrombocytopenia
1
2012
206
0.320
Why?
Comorbidity
5
2024
1665
0.320
Why?
Health Status Disparities
1
2014
322
0.320
Why?
Catheterization
1
2011
179
0.310
Why?
Electric Countershock
1
2011
126
0.310
Why?
Quality of Life
3
2022
3200
0.300
Why?
Adenosine Diphosphate
1
2009
75
0.300
Why?
Referral and Consultation
1
2016
881
0.290
Why?
Proportional Hazards Models
4
2021
1331
0.280
Why?
Nitric Oxide Synthase Type III
1
2009
199
0.280
Why?
Cardiovascular Agents
2
2022
165
0.280
Why?
Gene Expression Regulation, Enzymologic
1
2009
266
0.270
Why?
Double-Blind Method
5
2026
2070
0.270
Why?
AMP-Activated Protein Kinases
1
2009
193
0.270
Why?
Prospective Studies
8
2024
8123
0.260
Why?
Vascular System Injuries
2
2019
79
0.260
Why?
Retrospective Studies
9
2024
17438
0.260
Why?
Peptides
1
2013
992
0.260
Why?
Cardiomyopathies
1
2011
340
0.250
Why?
Defibrillators, Implantable
1
2011
393
0.250
Why?
Catheterization, Peripheral
2
2019
116
0.250
Why?
Healthcare Disparities
1
2014
733
0.250
Why?
Cause of Death
3
2018
456
0.240
Why?
Aged, 80 and over
8
2026
8391
0.240
Why?
Pregnancy Complications, Cardiovascular
1
2026
83
0.230
Why?
Ankle Brachial Index
2
2022
41
0.220
Why?
Limb Salvage
2
2026
74
0.210
Why?
Kaplan-Meier Estimate
3
2021
970
0.200
Why?
Practice Guidelines as Topic
3
2017
1591
0.200
Why?
Arteries
2
2022
261
0.200
Why?
Age Factors
4
2016
3347
0.200
Why?
Thromboplastin
1
2023
67
0.190
Why?
Patient Discharge
3
2021
997
0.190
Why?
Endothelial Cells
1
2009
876
0.190
Why?
Neoplasms
2
2017
2954
0.190
Why?
Incidence
5
2021
2936
0.180
Why?
Migraine Disorders
1
2024
109
0.180
Why?
Myocardial Ischemia
2
2015
286
0.180
Why?
Longitudinal Studies
5
2018
3017
0.180
Why?
Numbers Needed To Treat
1
2021
7
0.170
Why?
Ulcer
1
2021
37
0.170
Why?
Odds Ratio
2
2022
1077
0.170
Why?
Lactones
1
2022
60
0.170
Why?
Exercise Therapy
2
2026
488
0.160
Why?
Walking
2
2022
546
0.160
Why?
Angioplasty, Balloon
1
2021
92
0.160
Why?
Syndrome
1
2021
380
0.160
Why?
Antineoplastic Agents, Phytogenic
1
2021
178
0.160
Why?
Cholesterol
1
2022
411
0.160
Why?
Cohort Studies
3
2026
6077
0.160
Why?
Clinical Trials as Topic
2
2017
1064
0.160
Why?
Pharmaceutical Preparations
1
2021
172
0.150
Why?
Hypertension
2
2022
1272
0.140
Why?
Patient Education as Topic
1
2024
770
0.140
Why?
Extremities
1
2020
142
0.140
Why?
United Kingdom
1
2020
377
0.140
Why?
Receptors, Purinergic P2Y12
1
2018
6
0.140
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2018
25
0.140
Why?
Aorta
1
2021
440
0.140
Why?
Hospitalization
2
2019
2475
0.140
Why?
Logistic Models
2
2026
2126
0.140
Why?
Antithrombins
1
2018
71
0.130
Why?
Non-ST Elevated Myocardial Infarction
1
2017
27
0.130
Why?
Stents
3
2020
554
0.130
Why?
Pyridines
1
2022
610
0.130
Why?
Plaque, Atherosclerotic
1
2017
60
0.120
Why?
ST Elevation Myocardial Infarction
1
2017
65
0.120
Why?
Intraoperative Complications
1
2017
157
0.120
Why?
Diabetes Mellitus, Type 2
2
2024
2623
0.120
Why?
Uric Acid
1
2017
167
0.110
Why?
Mortality
1
2018
375
0.110
Why?
Stress Disorders, Post-Traumatic
1
2024
892
0.110
Why?
Consensus
1
2017
467
0.110
Why?
North Carolina
1
2015
127
0.110
Why?
Blood Platelets
1
2018
382
0.110
Why?
Hospital Bed Capacity
1
2014
28
0.110
Why?
Hospitals, Low-Volume
1
2014
26
0.110
Why?
Antibodies, Monoclonal
2
2023
1512
0.110
Why?
Smoking
1
2022
1486
0.110
Why?
Clinical Trials Data Monitoring Committees
1
2014
3
0.100
Why?
Hospitals, High-Volume
1
2014
51
0.100
Why?
Heart Failure
3
2026
2329
0.100
Why?
Vascular Patency
1
2014
115
0.100
Why?
Diagnosis-Related Groups
1
2013
34
0.100
Why?
Prosthesis Design
2
2017
358
0.100
Why?
Professional Competence
1
2014
90
0.100
Why?
Diabetes Mellitus
1
2022
1101
0.090
Why?
Fee-for-Service Plans
1
2013
98
0.090
Why?
Survivors
1
2017
526
0.090
Why?
Guideline Adherence
1
2017
594
0.090
Why?
Platelet Factor 4
1
2012
36
0.090
Why?
Infusions, Intravenous
1
2013
432
0.090
Why?
Practice Patterns, Physicians'
2
2018
1408
0.090
Why?
Inflammation
1
2023
2919
0.090
Why?
Antibodies, Monoclonal, Humanized
1
2017
992
0.080
Why?
Smoking Cessation
2
2026
442
0.080
Why?
Prognosis
2
2021
4351
0.080
Why?
Naphthalimides
1
2009
1
0.080
Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2009
4
0.080
Why?
Prevalence
3
2024
2861
0.080
Why?
Heart Diseases
1
2013
343
0.080
Why?
Radiography, Interventional
1
2011
128
0.070
Why?
Reoperation
2
2024
645
0.070
Why?
Hospital Mortality
1
2014
1051
0.070
Why?
Predictive Value of Tests
1
2014
2113
0.070
Why?
Multivariate Analysis
2
2026
1543
0.070
Why?
Sensitivity and Specificity
1
2013
1998
0.070
Why?
Benzimidazoles
1
2009
191
0.070
Why?
Protein Isoforms
1
2009
391
0.070
Why?
Enzyme Activation
1
2009
759
0.070
Why?
Combined Modality Therapy
2
2021
1271
0.060
Why?
Case-Control Studies
1
2015
3647
0.060
Why?
Communication
1
2014
980
0.060
Why?
Phosphatidylinositol 3-Kinases
1
2009
384
0.060
Why?
Cattle
1
2009
940
0.060
Why?
Clinical Competence
1
2014
1272
0.060
Why?
Quality Improvement
1
2014
1354
0.060
Why?
Phosphorylation
1
2009
1724
0.050
Why?
Autoantibodies
1
2012
1500
0.050
Why?
Cell Movement
1
2009
951
0.050
Why?
Adult
3
2026
41087
0.050
Why?
Fibromuscular Dysplasia
1
2024
8
0.050
Why?
Young Adult
1
2021
14330
0.050
Why?
Atherectomy
1
2024
37
0.050
Why?
Subtilisin
1
2023
4
0.050
Why?
Proprotein Convertases
1
2023
16
0.050
Why?
Angiography
1
2024
206
0.050
Why?
Arrhythmias, Cardiac
1
2026
358
0.050
Why?
Lipoprotein(a)
1
2023
70
0.050
Why?
Proprotein Convertase 9
1
2023
88
0.050
Why?
Disability Evaluation
1
2024
297
0.050
Why?
Pregnancy
2
2026
7230
0.040
Why?
Mobility Limitation
1
2022
68
0.040
Why?
Adolescent
1
2021
22557
0.040
Why?
Coated Materials, Biocompatible
1
2021
64
0.040
Why?
Public Health Surveillance
1
2021
84
0.040
Why?
Diagnostic Tests, Routine
1
2021
109
0.040
Why?
Internationality
1
2020
156
0.040
Why?
Length of Stay
1
2026
1358
0.040
Why?
Disease Susceptibility
1
2021
339
0.040
Why?
Punctures
1
2019
40
0.040
Why?
Advisory Committees
1
2021
228
0.040
Why?
Chronic Disease
1
2025
1827
0.040
Why?
Global Health
1
2021
403
0.030
Why?
Drug Utilization Review
1
2017
60
0.030
Why?
Health Care Costs
1
2021
423
0.030
Why?
Dose-Response Relationship, Drug
1
2021
2022
0.030
Why?
Socioeconomic Factors
1
2021
1327
0.030
Why?
Surgery, Computer-Assisted
1
2017
87
0.030
Why?
Comparative Effectiveness Research
1
2017
171
0.030
Why?
Chi-Square Distribution
1
2017
517
0.030
Why?
Signal Transduction
1
2009
5246
0.030
Why?
Platelet Function Tests
1
2015
37
0.030
Why?
Drug Prescriptions
1
2017
314
0.030
Why?
Genetic Predisposition to Disease
1
2024
2488
0.030
Why?
Patient Selection
1
2019
728
0.030
Why?
Administration, Oral
1
2017
872
0.030
Why?
Early Termination of Clinical Trials
1
2014
18
0.030
Why?
Hypoglycemic Agents
1
2024
1412
0.030
Why?
Depression
1
2024
1575
0.030
Why?
Retreatment
1
2013
79
0.020
Why?
Canada
1
2014
432
0.020
Why?
Mass Screening
1
2021
1307
0.020
Why?
Linear Models
1
2014
857
0.020
Why?
Patient Preference
1
2014
226
0.020
Why?
Animals
1
2009
38107
0.020
Why?
Hess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)